Archive for June, 2014

Results in Phase I trial of OMP-54F28, a Wnt inhibitor targeting cancer stem cells

At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharma…